Theravance Biopharma, Inc. (TBPH)

18.84 +0.11 (+0.59%) USD  |  NASDAQ  |  Dec 26, 16:00
18.85 +0.01 (+0.05%) After-Hours: 20:00
More

Theravance Biopharma Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Corcept Therapeutics, Inc. --
Perspective Therapeutics, Inc. --
Skye Bioscience, Inc. --
FibroGen, Inc. --
Myomo, Inc. --